(Q38054039)

27 August 2017

title

Identification of circulating microRNAs as biomarkers in cancers: what have we got? (English)

1 reference

27 August 2017

0 references

1 reference

Yu Sun

1

1 reference

27 August 2017

Kuo Zhang

series ordinal

2

1 reference

27 August 2017

Gaowei Fan

series ordinal

3

1 reference

27 August 2017

Jinming Li

series ordinal

4

1 reference

27 August 2017

publication date

1 December 2012

1 reference

Clinical Chemistry and Laboratory Medicine

27 August 2017

published in

1 reference

27 August 2017

volume

50

1 reference

27 August 2017

issue

12

1 reference

27 August 2017

page(s)

2121-2126

1 reference

Circulating microRNAs as biomarkers - True Blood?

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Circulating microRNAs, potential biomarkers for drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Serum microRNAs as non-invasive biomarkers for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

The majority of microRNAs detectable in serum and saliva is concentrated in exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

High-throughput miRNA profiling of human melanoma blood samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Circulating microRNAs (miRNA) in serum of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Analysis of circulating microRNA: preanalytical and analytical challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Characterization of extracellular circulating microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Circulating microRNAs in plasma of patients with gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

Systemic microRNAs: novel biomarkers for colorectal and other cancers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM-2012-0360

21 January 2018

Identifiers

DOI

10.1515/CCLM-2012-0360

1 reference

27 August 2017

1 reference